Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Barreto Plaza, Julián Andres"'
Publikováno v:
1. Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-2390.
2. Elias Campo and Simon Rule, Mantle cell lymphoma: evolving management strategies, Blood. 2015, VOLUME 12.
3. Karin E. Smedby, Henrik Hjalgrim; Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Seminars in Cancer Biology 21 (2011) 293–298.
4. Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer. 2002;38:401-408.
5. Caballero D, Campo E, Lopez-Guillermo A, et al. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Ann Hematol. 2013;92(9):1151–1179.
6. Julie M. Vose, Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management, Am J Hematol. 2017;92:806–813.
7. Elias Campo and Pedro Jares, Mantle Cell Lymphoma, Hematopathology, Second Edition, capitulo 22, Copyright © 2017 by Elsevier.
8. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identi-fies the cyclin D1 negative subtype. Haematologica. 2009;94:1555-1562.
9. Dictor M, Ek S, Sundberg M, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma. Haematologica. 2009;94:1563-1568.
11. Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 2012;122:3416-23.
12. Gesk S, Klapper W, Martín-Subero JI, et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006; 108: 1109-10.
13. ZengW,FuK,Quintanilla-FendL,LimM,OndrejkaS,HsiED.CyclinD1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol 2012;36:214–9.
14. Ting-Xun Lu, Jian-Yong Li, The role of SOX11 in mantle cell lymphoma, Leukemia Research 37 (2013) 1412–1419.
Patricia Balsas et al. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma; Blood. 2017;130(4):501-513
16. Lina Nygren et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma; Blood. 2012 VOLUME 119, NUMBER 18.
17. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008; 111:558–65.
18. Venera Kuci, Lena Nordström; Emerging role of SOX11 in mantle cell lymphoma, Blood and Lymphatic Cancer: Targets and Therapy 2015:5 35–42.
19. Roshni Narurkar, Mohammad Alkayem and Delong Liu, SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma; Narurkar et al. Biomarker Research (2016) 4:6
20. Wang X, Asplund AC, Porwit A, et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 2008;143(2):248-252.
2. Elias Campo and Simon Rule, Mantle cell lymphoma: evolving management strategies, Blood. 2015, VOLUME 12.
3. Karin E. Smedby, Henrik Hjalgrim; Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Seminars in Cancer Biology 21 (2011) 293–298.
4. Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer. 2002;38:401-408.
5. Caballero D, Campo E, Lopez-Guillermo A, et al. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Ann Hematol. 2013;92(9):1151–1179.
6. Julie M. Vose, Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management, Am J Hematol. 2017;92:806–813.
7. Elias Campo and Pedro Jares, Mantle Cell Lymphoma, Hematopathology, Second Edition, capitulo 22, Copyright © 2017 by Elsevier.
8. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identi-fies the cyclin D1 negative subtype. Haematologica. 2009;94:1555-1562.
9. Dictor M, Ek S, Sundberg M, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma. Haematologica. 2009;94:1563-1568.
11. Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 2012;122:3416-23.
12. Gesk S, Klapper W, Martín-Subero JI, et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006; 108: 1109-10.
13. ZengW,FuK,Quintanilla-FendL,LimM,OndrejkaS,HsiED.CyclinD1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol 2012;36:214–9.
14. Ting-Xun Lu, Jian-Yong Li, The role of SOX11 in mantle cell lymphoma, Leukemia Research 37 (2013) 1412–1419.
Patricia Balsas et al. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma; Blood. 2017;130(4):501-513
16. Lina Nygren et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma; Blood. 2012 VOLUME 119, NUMBER 18.
17. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008; 111:558–65.
18. Venera Kuci, Lena Nordström; Emerging role of SOX11 in mantle cell lymphoma, Blood and Lymphatic Cancer: Targets and Therapy 2015:5 35–42.
19. Roshni Narurkar, Mohammad Alkayem and Delong Liu, SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma; Narurkar et al. Biomarker Research (2016) 4:6
20. Wang X, Asplund AC, Porwit A, et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 2008;143(2):248-252.
El linfoma de células del manto (LCM) es una neoplasia linfoproliferativa originada en células B maduras, su diagnóstico requiere la integración de una morfología típica y variantes, junto con características inmunofenotípicas evaluadas por m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2802::fe6b74db2e09d6877bc746e3925a1ce3
https://hdl.handle.net/10654/21127
https://hdl.handle.net/10654/21127
